230 results
·
36ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
QUANTIMUNE DIGOXIN RIA/DIGOXIN RIA
FDA 510(k)
FDA Class 2
·Clinical Toxicology
VARIANT BETA-THALASSEMIA SHORT PROGRAM
FDA 510(k)
FDA Class 2
·Hematology
LIQUICHEK ANTI-SS-B CONTROL, EIA, MODEL 210
FDA 510(k)
FDA Class 2
·Immunology
PLATELIA LYME IGG ASSAY
FDA 510(k)
FDA Class 2
·Microbiology
LIQUICHEK ANTI-SMOOTH MUSCLE CONTROL, POSITIVE, CATALOG #129
FDA 510(k)
FDA Class 2
·Immunology
MRSASELECT
FDA 510(k)
FDA Class 2
·Microbiology
LYPHOCHEK HEMOGLOBIN ALC LINEARITY SET
FDA 510(k)
FDA Class 2
·Hematology
QUANTIMUNE T-3 RIA
FDA 510(k)
FDA Class 2
·Clinical Chemistry
LIQUICHEK ANTI-NDNA CONTROL, POSITIVE, CATALOG #119
FDA 510(k)
FDA Class 2
·Immunology
LIQUICHEK ANA CONTROL HOMOGENEOUS PATTERN CONTROL, POSOTIVE, CATALOG #118
FDA 510(k)
FDA Class 2
·Immunology
QUANTIMUNE(R) FERRITIN IRMA
FDA 510(k)
FDA Class 2
·Immunology
VARIANT II B-THALASSEMIA
FDA 510(k)
FDA Class 2
·Hematology
LIQUICHEK D-DIMER CONTROL LEVEL 1, 2 AND 3
FDA 510(k)
FDA Class 2
·Hematology
LIQUICHEK ANTI-SS-A CONTROL, EIA, MODEL 209
FDA 510(k)
FDA Class 2
·Immunology
RADIAS FERRITIN ENZYME IMMUNOASSAY
FDA 510(k)
FDA Class 2
·Immunology
LIQUICHEK ANTI-SM CONTROL, EIA, MODEL 208
FDA 510(k)
FDA Class 2
·Immunology
BENZODIAZEPINES AND TRICYCLIC ANTIDEPRESSANTS BY HPLC
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LYPHOCHEK HEMOGLOBIN AIC CONTROL HUMAN
FDA 510(k)
FDA Class 2
·Hematology
BIO.RAD HEMOGLOBIN A1 BY COLUMN TEST
FDA 510(k)
FDA Class 2
·Hematology
DETER. OF HEMOGLOBIN A2 USING THE DIAMAT
FDA 510(k)
FDA Class 2
·Hematology